Shepherd, A. I., James, T. J., Gould, A. A. M., Mayes, H., Neal, R., Shute, J., Tipton, M. J., Massey, H., Saynor, Z. L., Perissiou, M., Montgomery, H., Sturgess, C., Makaronidis, J., Murray, A. J., Grocott, M. P. W., Cummings, M., Young-Min, S., Rennell-Smyth, J., McNarry, M. A., Mackintosh, K. A., Dent, H., Robson, S. C. and Corbett, J., 2024. Impact of nocturnal hypoxia on glycaemic control, appetite, gut microbiota and inflammation in adults with T2DM: A single-blind crossover trial. The Journal of Physiology, 602 (21), 5835-5854.
Full text available as:
|
PDF (OPEN ACCESS ARTICLE)
The Journal of Physiology - 2024 - Shepherd - Impact of nocturnal hypoxia on glycaemic control appetite gut microbiota.pdf - Published Version Available under License Creative Commons Attribution. 2MB | |
PDF (OPEN ACCESS ARTICLE)
The Journal of Physiology - 2024 - Shepherd - Impact of nocturnal hypoxia on glycaemic control appetite gut microbiota (1).pdf - Published Version Restricted to Repository staff only Available under License Creative Commons Attribution. 2MB | ||
Copyright to original material in this document is with the original owner(s). Access to this content through BURO is granted on condition that you use it only for research, scholarly or other non-commercial purposes. If you wish to use it for any other purposes, you must contact BU via BURO@bournemouth.ac.uk. Any third party copyright material in this document remains the property of its respective owner(s). BU grants no licence for further use of that third party material. |
DOI: 10.1113/JP285322
Abstract
High altitude residents have a lower incidence of type 2 diabetes mellitus (T2DM). Therefore, we examined the effect of repeated overnight normobaric hypoxic exposure on glycaemic control, appetite, gut microbiota and inflammation in adults with T2DM. Thirteen adults with T2DM [glycated haemoglobin (HbA1c): 61.1 ± 14.1 mmol mol−1; aged 64.2 ± 9.4 years; four female] completed a single-blind, randomised, sham-controlled, cross-over study for 10 nights, sleeping when exposed to hypoxia (fractional inspired O2 [ ] = 0.155; ∼2500 m simulated altitude) or normoxic conditions ( = 0.209) in a randomised order. Outcome measures included: fasted plasma [glucose]; [hypoxia inducible factor-1α]; [interleukin-6]; [tumour necrosis factor-α]; [interleukin-10]; [heat shock protein 70]; [butyric acid]; peak plasma [glucose] and insulin sensitivity following a 2 h oral glucose tolerance test; body composition; appetite indices ([leptin], [acyl ghrelin], [peptide YY], [glucagon-like peptide-1]); and gut microbiota diversity and abundance [16S rRNA amplicon sequencing]. During intervention periods, accelerometers measured physical activity, sleep duration and efficiency, whereas continuous glucose monitors were used to assess estimated HbA1c and glucose management indicator and time in target range. Overnight hypoxia was not associated with changes in any outcome measure (P > 0.05 with small effect sizes) except fasting insulin sensitivity and gut microbiota alpha diversity, which exhibited trends (P = 0.10; P = 0.08 respectively) for a medium beneficial effect (d = 0.49; d = 0.59 respectively). Ten nights of overnight moderate hypoxic exposure did not significantly affect glycaemic control, gut microbiome, appetite, or inflammation in adults with T2DM. However, the intervention was well tolerated and a medium effect-size for improved insulin sensitivity and reduced alpha diversity warrants further investigation.
Item Type: | Article |
---|---|
ISSN: | 0022-3751 |
Group: | Faculty of Health & Social Sciences |
ID Code: | 39860 |
Deposited By: | Symplectic RT2 |
Deposited On: | 22 May 2024 08:21 |
Last Modified: | 29 Nov 2024 16:19 |
Downloads
Downloads per month over past year
Repository Staff Only - |